Skip to content
Screener

Clarivate CLVT Life Sciences & Healthcare — Impact of foreign currency fluctuations

Other segment segments

A&G
$25K+105%
IP
$0

Similar metrics at other companies

IQVIA logo
IQVCommercial Solutions — Impact of foreign currency fluctuations and other
-$39M
Revvity logo
RVTYLife Sciences — Foreign currency translation
-$24.95M-174%
ExlService Holdings logo
EXLSHealthcare and Life Sciences — Currency translation adjustments
-$29K-3,000%
IQVIA logo
IQVResearch & Development Solutions — Impact of foreign currency fluctuations and other
-$6M-127%
Nelnet logo
NNINelnet Bank — Effect of foreign currency fluctuations
$0
Danaher logo
DHRLife Sciences — Goodwill, Foreign Currency Translation, Gain (Loss)
$135.5M+374%

Other financials

Income statement

See full
Revenue$587.3M-5.5%
Gross profit$401.8M-3.8%
Operating income-$200.2M-3,001%
Net income-$268.6M-273%
EPS (diluted)-$0.42-282%

Balance sheet

See full
Cash & equivalents$217.7M-40.0%
Total debt$4.3B-7.4%
Total equity$4.5B-9.1%
Total assets$10.5B-8.2%

Cash flow

See full
Operating cash flow$98.7M-15.1%
CapEx$54.7M-17.1%
Free cash flow$44.0M-12.5%

Valuation

See full
Market cap$1.18B-53.4%
Enterprise value$5.29B-22.7%
P/S0.5×-0.5×

Profitability

See full
Gross margin66.8%+0.8pp
Operating margin-3.5%+5.5pp
Net margin-14%-2.3pp
FCF margin13.6%-0.3pp

Returns & leverage

See full
Return on equity-7.1%-0.8pp
Debt / equity0.0×
Current ratio0.8×-0.1×

Where this comes from

Reported directly by Clarivate in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The source filing: Clarivate’s 10-K, filed February 24, 2026.

Filed
Feb 24, 2026, 6:04 AM EST
Fiscal year
FY2025
Accession
0001764046-26-000019
Line itemA&GIPLS&HTotal Consolidated
Acquisition13.815.829.6
Goodwill impairment(13.8)(451.9)(465.7)
Divestiture(1)(20.6)(20.6)
Impact of foreign currency fluctuations(0.4)(0.4)
Balance as of December 31, 2024$1,088.8$—$477.8$1,566.6
Impact of foreign currency fluctuations0.10.1
Balance as of December 31, 2025$1,088.9$—$477.8$1,566.7
(1) Related to the ScholarOne divestiture and its allocated portion of the A&G segment reporting unit’s goodwill balance. For further details, see Note 2 - Acquisitions and Divestitures.

Item 8. Financial Statements and Supplementary Data.

FAQ

What is Clarivate's life sciences & healthcare — impact of foreign currency fluctuations?
Clarivate (CLVT) reported life sciences & healthcare — impact of foreign currency fluctuations of $0 in Q4 2025.
What is the long-term trend for Clarivate's life sciences & healthcare — impact of foreign currency fluctuations?
Over 3 years (2021 to 2025), Clarivate's life sciences & healthcare — impact of foreign currency fluctuations has grown at a -100.0% compound annual growth rate (CAGR), from $700K to $0.
What does life sciences & healthcare — impact of foreign currency fluctuations mean?
This metric quantifies the impact of exchange rate volatility on the reported financial results of the Life Sciences & Healthcare segment. It isolates the variance in revenue or operating performance caused by currency movements rather than underlying operational changes. Tracking this helps stakeholders distinguish between organic business performance and external macroeconomic factors affecting international operations.

Ask your AI about Clarivate's life sciences & healthcare — impact of foreign currency fluctuations.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude